Table 3.
PSI Characteristics | n (%) |
---|---|
Types of PSIsa: | |
Medication | 21 (58.3%) |
Monitoring | 15 (41.7%) |
Diagnosis and diagnosing | 9 (25%) |
Coding/record keeping | 7 (19.4%) |
Investigations | 7 (19.4%) |
Communication | 6 (16.6%) |
Unclear/insufficient info to classify | 3 (8.3%) |
Medications most commonly implicated in PSIsb: | |
Diuretics | 8 (38.1%) |
ACEI/ARBs | 3 (14.3%) |
Opiates | 3 (14.3%) |
Antibiotics | 2 (9.5%) |
Warfarin | 2 (9.5%) |
Other hypoglycaemic agents | 1 (4.8%) |
NSAIDs including aspirin | 1 (4.8%) |
Not specified | 3 (14.3%) |
Note. aFigures do not total to 36 as some PSIs fall within more than one of the categories
bFigures do not total to 21 as more than one medication was implicated in the instance of some PSIs
ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin II receptor blockers, NSAID nonsteroidal anti-inflammatory drug